MCHALE DUNCAN (Chief Medical Officer) sold 30.2% of their position (3.43K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $32.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/9/2023ACC: 0001694665-23-000134
Officer· Chief Medical Officer
Since Jan 2020
-3.43K
Net shares
Net seller
$32.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.50K acquired · 9.93K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.50K
Price / share
—
Trade value
—
% of position
133.3%
8/7/2023
4.88K→11.38K
Common Stock
Direct
Shares
−3.43K
Price / share
$9.51
Trade value
$32.66K
% of position
30.2%
8/8/2023
11.38K→7.94K
Total
Net shares
+3.07K
Net value
-$32.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2023 | M · Option Exercise | +6.50K | — | — | 133.3% | 4.88K | 11.38K |
| Common Stock Direct | 8/8/2023 | S · Sale | −3.43K | $9.51 | $32.66K | 30.2% | 11.38K | 7.94K |
| Total | +3.07K | -$32.66K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.50K shares
Shares
−6.50K
Strike price
Held after
13K
Exercisable
—
8/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.50K shares | 8/7/2023 | M · Option Exercise | −6.50K | — | 13K |